BIOMEDOMICS, INC.
RESEARCH TRIANGLE PARK, NC · CIK 0001595601 · Medtech · Acquired
Point-of-care diagnostic device for sickle cell disease detection in low-resource settings
- Grants
- $1.2M
- 3 awards
- Sector median: 1
- Raised
- $1.5M
- 3 Form D · Jul 2017
- 110 months since last filing
- Contracts
- $2.1M
- 7 awards · Health and Human S, Defense
- #217 of 4531 in medtech
- Patents
- 13
- 2 granted · 11 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2006200820102012201420162018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · 200-2007-M-21487 - Biomedomics, Inc. | $814,760 | |
| Federal contract | Department of Defense · Army SBIR Phase 1 A083-173-0330 | $69,996 | |
| Federal contract | Department of Health and Human Services · R&d-drug Dependency-mgmt Sup | $99,992 | |
| Federal contract | Department of Health and Human Services · TAS::75 0872::TAS SBIR Topic 46 | $99,932 | |
| Federal contract | Department of Health and Human Services · TAS::75 0893::TAS Multiplexed Sensitive Testing For Drugs Of Abuse | $99,989 | |
| Federal contract | Department of Health and Human Services · TAS::75 0849::TAS | $199,635 | |
| Federal contract | Department of Health and Human Services · TAS::75 0893::TAS Multiplexed Sensitive Testing For Drugs Of Abuse | $745,047 | |
| Private capital raised | Form D · SEC | $690,000 | |
| Private capital raised | Form D · SEC | $275,752 | |
| Federal grant | Department of Health and Human Services · Phase I · Rapid, Near-Patient Tests to Monitor and Guide Therapy in Sickle Cell Disease Patients | $222,958 | |
| Federal grant | Department of Health and Human Services · Phase II · Sickle SCAN(R) - A rapid, qualitative test to aid in the diagnosis of sickle cell disorders | $496,086 | |
| Federal grant | Department of Health and Human Services · Phase II · Sickle SCAN(R) - A rapid, qualitative test to aid in the diagnosis of sickle cell disorders | $496,086 | |
| Private capital raised | Form D · SEC | $530,000 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 214 | DREAM SYSTEMS, LLC | $2.2M | — |
| 215 | X-Therma Inc. | $2.2M | $35M |
| 216 | FARUS, LLC | $2.1M | — |
| 217 | BIOMEDOMICS, INC. | $2.1M | $1.5M |
| 218 | BASE PAIR BIOTECHNOLOGIES INC | $2.1M | $1.9M |
| 219 | Prentke Romich Company | $2.1M | — |
| 220 | ATTUNE NEUROSCIENCES, INC. | $2.0M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- CAM PATTERSONDirector
- TOM ROBERGDirector
- J. TYLER, IIIExecutive Officer
- FRANK WANGDirector · Executive Officer
- PHILLIP WISEExecutive Officer
- LIN WUDirector
Patents
- Lateral Flow Immunoassay Method Of Simultaneously Detecting Hemoglobin S, Hemoglobin C, And Hemoglobin A In Newborns, Infants, Children, And Adultsapplication
- Nanotube Based Lateral Flow Device For Biomarker Detectiongranted
- Devices, Systems And Methods For Quantifying Hemoglobin S Concentrationapplication
- Nanotube Based Lateral Flow Device for Biomarker Detectiongranted
- Lateral Flow Immunoassay Method Of Simultaneously Detecting Hemoglobin S, Hemoglobin C, And Hemoglobin A In Newborns, Infants, Children, And Adultsapplication
- Lateral Flow Immunoassay Methods And Devices For Simultaneously Detecting Hemoglobin S, Hemoglobin C, And Hemoglobin A In Newborns, Infants, Children, And Adultsapplication
- Lateral Flow Immunoassay Method Of Simultaneously Detecting Hemoglobin S, Hemoglobin C, And Hemoglobin A In Newborns, Infants, Children, And Adultsapplication
- Detection Of Disease Related Gene Mutations By Single Molecule Amplification With Multiplex Ligation Assaysapplication
- A Rapid And Sensitive Method For Quantitative Determination Of The Level Of HEPARIN-PF4 Complex Induced Immunoglobulin Antibodiesapplication
- Devices Systems And Methods For Quantifying Hemoglobin S Concentrationapplication
- Lateral Flow Immunoassay Devices, Systems And Methods For Detecting Alpha- Thalassemia 1 Trait Southeast Asian (sea) Typeapplication
- Method For Quantifying Hemoglobin S Concentration For Sickle Cell Disease Patientapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.